Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
09 May 2019 | Story Ruan Bruwer | Photo Varsity Sports
Lefébre Rademan
Lefébre Rademan, new captain of the Free State Crinums netball team, could be one of the star players in the Premier League. She is a fifth-year Education student.

The Free State Crinums netball team, a de facto Kovsie team with all 15 squad members enrolled for courses at the University of the Free State (UFS), will draw inspiration from their success in last year’s Varsity netball tournament. The Kovsies won the student competition for a record third time. 

During the weekend of 10 May 2019, the Crinums will play their first match in the 2019 Premier League. They lost a couple of key players in captain Alicia Puren, Protea Khanyisa Chawane, (both playing for the national invitational team in the league), Khomotso Mamburu (moved to Cape Town), and Meagan Roux (injured). They do, however, still have the services of players such as Tanya von Berg (playing in her sixth Premier League, one of only a handful of players to do so), Lefébre Rademan, Sikholiwe Mdletshe, Ané Retief, Gertriana Retief, and Rieze Straeuli. Rademan is the new captain and was one of the standout players in last year’s Varsity netball, earning three Player of the Match awards, including the Player of the Final. 

The team will again be coached by Burta de Kock, who is also the head coach of the Kovsies. Under her leadership, the Crinums won the Premier League for the first three years (2014 to 2016). Last year, the Crinums ended fourth. De Kock will be assisted by Martha Mosoahle-Samm. She is a former Protea assistant coach who also captained South Africa and played for the UFS between 1997 and 1999.

There are four first-year students in the squad of 15 players: Oageng Khasake (wing attack), Ancia Pienaar (goalkeeper), Rolene Streutker (goal shooter), Boitumelo Mahloko (goal defence). Pienaar and Mahloko both represented South Africa at junior level in 2018.

■ Crinums squad: Ané Retief, Gertriana Retief, Jana Scholtz, Lefébre Rademan, Sikholiwe Mdletshe, Tanya von Berg, Rieze Straeuli, Claudia van den Berg, Zandré Smit, Oageng Khasake, Bianca de Wee, Ancia Pienaar, Rolene Streutker, Chanel Vrey, Boitumelo Mahloko.


News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept